Status:
UNKNOWN
Does Omega-3 Fatty Acid Supplementation in Pregnancy and During Lactation Protect the Child From Allergic Disease?
Lead Sponsor:
Linkoeping University
Collaborating Sponsors:
Pharma Nord
The Ekhaga Foundation, Stockholm, Sweden
Conditions:
Allergies
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The incidence of allergic diseases has increased and a relation between allergy and dietary fatty acids has been proposed. Modulation of the maternal immune function during pregnancy may have an impac...
Eligibility Criteria
Inclusion
- Pregnant woman, at 25 weeks of gestation, with allergic symptoms (rhinitis, conjunctivitis, eczema, asthma or food allergy) herself or the father to be or an older sibling
Exclusion
- Soy allergy
- Fish allergy
- Treatment with anti-coagulation
- Commercial omega-3 supplementation
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT00892684
Start Date
March 1 2003
End Date
September 1 2011
Last Update
May 4 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Linköping, Sweden, 58185